Trial
NCT04320290
HCV + to HCV - Kidney Transplant
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Kidney Failure
Intervention
Direct Acting Antivirals
Why stopped
New Related Protocol to be submitted
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-31